This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

90% Of Pharmaceutical Professionals See Positive Business Environment In Advance Of CPhI Worldwide 2012 - The Leading Global Gathering Of The Pharmaceutical Industry

AMSTERDAM, Oct. 6, 2012 /PRNewswire/ -- In its ongoing commitment to driving growth and innovation in the global pharmaceutical industry, UBM Live's CPhI portfolio today released the results of a pre-event survey indicating positive growth expectation and insights into the development and manufacturing of pharmaceutical products. According to the survey, 97% of visitors expect sales to increase or stay the same over the next 12 months (up from 90% over the last 12 months), and 90% rate their business opportunity in the global pharmaceutical market positively. Attendees expect pockets of innovation to positively impact their overall business including GMP certification (64.8%), the rise in generics (58.6%), the move toward outsourcing (53.4%) and supply chain security (50.4%). The visitors polled represent pharmaceutical buyers who plan to attend CPhI Worldwide, set from 9-11 October at the Feria de Madrid in Spain. CPhI and co-located events ICSE, InnoPack and P-MEC Europe host 2,200 suppliers offering ingredients, finished dosage, contract services, equipment, and packaging.  

"As part of our ongoing commitment to driving growth and innovation in the global pharmaceutical market, CPhI provides an efficient and effective platform for the most active buyers to identify business opportunities and meet with potential partners to move the industry forward," commented CPhI Portfolio Director, Greg Kerwin. "Despite global economic uncertainly, we are enthused to see such optimism and focus on innovation from the leaders in the pharmaceutical industry."

The recently completed CPhI Worldwide survey polled nearly 1,100 pre-registered visitors via email and found the following top line results:
  • 90% of visitors rate their business opportunity in the global pharmaceutical market positively
  • 97% of visitors expect sales to increase or stay the same over the next 12 months (vs. 90% over the last 12 months)
  • 61% (6 out of 10) of visitors said that the current economic climate will have no impact or a positive impact on their business
  • 53.2% of visitors said that the move towards outsourcing will have a positive impact on their business (vs. 8% negative and 30.3% neutral)
  • 91% of visitors said they use internet to source products/services
  • 90% of visitors rate sustainability as important to the future development of their company (71% have a sustainability policy in place or in progress)

"At this year's CPhI we've made significant investments to improve visitor experience and exhibitor return-on-investment to ensure valuable connections are made easily and productively by the various event participants," stated Andrew Pert, CPhI Brand Director. "We've introduced CPhI Global Meetings which offers personalised matchmaking for pre-scheduled, highly targeted meetings. A mobile app has launched which includes pre-show planning tools, real time navigation of the event, and a platform for networking and information exchange with more than 5,000 downloads. Additionally, the popular zoning format has expanded to make locating business partners as easy as possible."

As a further reflection of growth in the global pharma market, CPhI Worldwide expects visitors and exhibitors from more than 140 countries. This includes two new Global Pavilions, one for Malaysia and one for Russia. Overall, a record of fifteen country pavilions will be represented at CPhI Worldwide including Asian API market leaders from China and India, as well as Korea. Pavilions for Argentina and Brazil spotlight the two largest economies in South America. Europe is highlighted by pavilions for the UK, France, Ireland, Scotland, and Portugal, while North Africa, Egypt and Morocco represent Africa. The North American pavilion also returns, featuring support from Society of Chemical Manufacturers and Associates (SOCMA) for the first time.

The pavilions are further supported by global partnerships with the India Brand Equity Foundation (IBEF), the Ministry of Industry and Trade of the Russian Federation and Malaysia's MATRADE. Also complementing the global expansion of the event, a series of geography focused lunchtime educational sessions will run each day with keynote presentations from event partners, China Chamber of Commerce for Import & Export & Export of Medicines & Health Products (CCCMHPIE) and India's Pharmexcil.

Online registration is open now and on-site pricing will open at the venue on Sunday 7 October and runs through event days. To learn more about the events, and to register, please visit

The annual UBM Live Pharma Portfolio of events also includes CPhI, ICSE, P-MEC India and BioPh ( 21-23 November, 2012 at the Bombay Exhibition Centre in Mumbai); CPhI, P-MEC, InnoPack South East Asia ( 20-22 March, 2013 at the Jakarta International Expo in Indonesia); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan ( 24-26 April, 2013 at the Tokyo Big Sight Exhibition Centre in Japan); CPhI, P-MEC, ICSE, InnoPack, LABWorld, BioPh China ( 25-27 June 2013 at the SNIEC in Shanghai); and CPhI South America ( 6-8 August 2013 at the Expo Centre Norte, Sao Paulo, Brazil).

About UBM Live:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,050.75 +138.46 0.82%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,810.7880 +19.6360 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs